Age: 17.0
Sex: M
Vaccine: FLU4, HEPA, HPV9, IPV, MMR, VARCEL
Symptoms: Cold sweat, Dizziness, Immediate post-injection reaction, Pallor
Clinical narrative: felt dizzy; cold clammy skin; pale; This spontaneous report was received from a registered nurse via health authority FDA (VAERS ID 810447) on 08-JAN-2020 concerning a 17-year-old male patient. The patient's concurrent conditions included asthma. The patient's medical history included dizziness. Historical vaccines included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (TDAP), measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (manufacturer unknown), hepatitis B virus vaccine (unspecified), and meningococcal ACYW conj vaccine (carrier unspecified).   On 15-APR-2019 at 10:33, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (route not reported) dose 1 in the left arm (lot # R019469 and expiration date 10-APR-2021), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneously, dose 2 in the right arm (lot # R000555 and expiration date 08-JAN-2020), varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously, dose 1 in the left arm (lot # reported as R19236 (Lot number R19236 is an invalid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast))), influenza virus split virion 4v vaccine inactivated (FLUZONE) intramuscularly, dose 1 in the right arm (lot # UI982AB), hepatitis a virus vaccine inactivated (HAVRIX) intramuscularly, dose 1 in the right arm (lot # 2GY7E), and poliovirus vaccine inactivated (vero) (IPOL) subcutaneously, dose 4 in the left arm (lot # PIA242M); all administered for prophylaxis. On the same date at the same time, the patient felt dizzy with cold clammy skin and pale immediately after last vaccine was administered. Vital signs (VS) were as follows: blood pressure (BP) was 100/70 (units not provided), respiratory rate (R) was 24 (units not provided), and pulse (P) was 76 (units not provided) sitting with the head the between legs. Then, at 10:41, the patient was feeling better, color better, cool compress applied to neck and face. At 10:50, he was feeling better, color returned, BP was 110/80 (units not provided), P was 64 (units not provided), R was 32 (units not provided), and rechecked R was 29 (units not provided). Finally, at 10:56 Left walking out of clinic accompanied by his father. On an unspecified day in April 2019, the patient recovered from the events.  The causal relationship between the events and the vaccines was not reported.  Follow-up information has been received from the registered nurse on 25-FEB-2020, via a telephone call. The reporter confirmed the date of administration along with the age and gender of the patient. The patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R019236 (previously reported as R19236), expiration date not reported, but upon internal validation established as 04-JUL-2020. On 15-APR-2019, the patient completely recovered from the events. The nurse clarified that the patient was referred by this public health office to seek any future treatment or/and vaccinations with a private primary care provider. Additional information has been requested.